IQ-EQ supports Pegasus Europe, Europe’s largest SPAC to date

IQ-EQ has been proud to support special purpose acquisition company (SPAC), Pegasus Europe. Having successfully raised €500 million in a private placement, Pegasus is the largest European SPAC to date.

Pegasus Europe was referred to IQ-EQ Netherlands by Tikehau Capital, a pan-European alternative asset manager with whom IQ-EQ has a long-standing, trusted relationship. Tikehau Capital, alongside co-sponsors Financière Agache (the investment holding company of LVMH chairman Bernard Arnault), Jean Pierre Mustier and Diego De Giorgi, launched Pegasus in February 2021.

Following its successful IPO, Pegasus Europe began trading on Euronext Amsterdam on 29 April. The SPAC is set to focus on investments in Europe’s financial services sector, with potential targets including asset management platforms, insurance services, diversified financial services companies as well as financial technology companies.

Led by director Emma Causevic, IQ-EQ Netherlands is delivering a full suite of corporate services to Pegasus Europe, including audit assistance, accounting and reporting, corporate secretarial, registered office, tax compliance support, HR administration and payroll services.

Commenting on the relationship with IQ-EQ, Pegasus Europe’s Chief Financial Officer, Mike Assouline, said:

“It has been a real pleasure to partner with IQ-EQ throughout the process; I’ve particularly appreciated their availability and responsiveness, which are of course critical factors when dealing with SPACs and listed companies. I look forward to working closely with the IQ-EQ team as we progress Pegasus’ investment strategy.”

IQ-EQ is seeing a significant increase in the use of SPACs, which allow investors to pool resources in a public investment vehicle with the intent to acquire existing businesses. Click here to find out more about our comprehensive service offering for SPACs and other company structures.

If you have any questions about SPACs specifically, please contact Emma Causevic at or on +31 20 522 25 72.